X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22) 22
humans (19) 19
adult (12) 12
female (12) 12
middle aged (12) 12
male (11) 11
oncology (11) 11
melanoma - therapy (8) 8
young adult (7) 7
animals (6) 6
immunotherapy (6) 6
melanoma - immunology (6) 6
treatment outcome (6) 6
abridged index medicus (5) 5
adoptive immunotherapy (5) 5
aged (5) 5
gene therapy (5) 5
lymphocytes, tumor-infiltrating - immunology (5) 5
tumor cells, cultured (5) 5
article (4) 4
immunotherapy, adoptive - adverse effects (4) 4
immunotherapy, adoptive - methods (4) 4
medicine, research & experimental (4) 4
metastatic melanoma (4) 4
mice (4) 4
pharmacology (4) 4
receptors, antigen, t-cell - genetics (4) 4
tcr (4) 4
adolescent (3) 3
adoptive transfer (3) 3
adults (3) 3
antitumor-activity (3) 3
cd8 t-cells (3) 3
clinical trials (3) 3
immunology (3) 3
infection (3) 3
infectious diseases (3) 3
lymphocytes, tumor-infiltrating - transplantation (3) 3
medicine, general & internal (3) 3
melanoma - mortality (3) 3
melanoma - pathology (3) 3
neoplasm metastasis (3) 3
receptors, antigen, t-cell - immunology (3) 3
t-lymphocytes - immunology (3) 3
transduction, genetic (3) 3
tumor-infiltrating lymphocytes (3) 3
vaccines (3) 3
viruses (3) 3
aids/hiv (2) 2
amiloride - analogs & derivatives (2) 2
amiloride - pharmacology (2) 2
antibodies (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - pharmacokinetics (2) 2
antigen (2) 2
antigens, neoplasm - immunology (2) 2
antineoplastic agents - pharmacology (2) 2
atp-binding cassette transporters - biosynthesis (2) 2
autoimmunity (2) 2
biotechnology & applied microbiology (2) 2
blood (2) 2
cancer (2) 2
cancer regression (2) 2
cd8-positive t-lymphocytes - immunology (2) 2
cd8-positive t-lymphocytes - transplantation (2) 2
cell survival - drug effects (2) 2
cells, cultured (2) 2
chemical and pharmacologic phenomena (2) 2
child (2) 2
cisplatin (2) 2
cisplatin - pharmacology (2) 2
cisplatin resistance (2) 2
combined modality therapy (2) 2
cross-linking reagents - pharmacology (2) 2
cytokines - immunology (2) 2
dose-response relationship, drug (2) 2
drug discovery (2) 2
drug resistance, multiple - genetics (2) 2
drug resistance, neoplasm (2) 2
drug-resistance (2) 2
enzyme-linked immunosorbent assay (2) 2
epidemics (2) 2
gene transfer techniques (2) 2
genetic therapy - methods (2) 2
genetic vectors (2) 2
genetics (2) 2
genetics & heredity (2) 2
glycoprotein (2) 2
health aspects (2) 2
hematology (2) 2
hydrogen-ion concentration (2) 2
hypersensitivity (2) 2
immunogenicity (2) 2
immunoglobulins (2) 2
immunotherapy, adoptive (2) 2
infections (2) 2
intravenous administration (2) 2
lymphocyte count (2) 2
lymphodepletion (2) 2
malignant-melanoma (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Molecular Therapy, ISSN 1525-0016, 03/2011, Volume 19, Issue 3, pp. 620 - 626
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 3, pp. 535 - 546
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 02/2013, Volume 36, Issue 2, pp. 133 - 151
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 17, pp. 2152 - 2159
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/1997, Volume 41, Issue 7, pp. 1521 - 1530
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/1997, Volume 72, Issue 6, pp. 1021 - 1026
Journal Article
Journal Article
Journal of immunotherapy (Hagerstown, Md. : 1997), ISSN 1524-9557, 2/2013, Volume 36, Issue 2, pp. 133 - 151
Nine cancer patients were treated with adoptive cell therapy using autologous anti-MAGE-A3 TCR engineered T cells. Five patients experienced clinical... 
TCR | Cancer Testes Antigen | Gene Therapy | Immunotherapy
Journal Article
Journal of immunotherapy (Hagerstown, Md. : 1997), ISSN 1524-9557, 2010, Volume 33, Issue 6, pp. 626 - 629
Adjuvants are requisite components of many vaccines designed to elicit T-cell immunity although the exact components of commonly used adjuvants are not always... 
melanoma | vaccine | Incomplete Freund’s Adjuvant | immunotherapy
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/1997, Volume 72, Issue 6, pp. 1021 - 1026
Journal Article